Aprea Therapeutics
Stock Forecast, Prediction & Price Target
Aprea Therapeutics Financial Estimates
Aprea Therapeutics Revenue Estimates
Aprea Therapeutics EBITDA Estimates
Aprea Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $583.23K 0% | Avg: $266.67K Low: $242.42K High: $290.91K avg. -54.27% | Avg: $266.67K Low: $242.42K High: $290.91K avg. 0% | Avg: $30.17M Low: $27.43M High: $32.91M avg. 11215.29% | Avg: $47.81M Low: $43.46M High: $52.16M avg. 58.46% |
Net Income
% change YoY
| $-36.53M N/A | $-224.87M -515.48% | $-14.28M 93.64% | Avg: $-20.99M Low: $-10.02M High: $-1.80M avg. -46.92% | Avg: $-27.05M Low: $-9.51M High: $-1.84M avg. -28.88% | Avg: $-2.72M Low: $-3.04M High: $-2.40M avg. 89.92% | Avg: $-952.62K Low: $-1.06M High: $-840.04K avg. 65.04% |
EBITDA
% change YoY
| $-37.76M N/A | $38.36M 201.59% | $-14.27M -137.21% | Avg: $160.00K Low: $145.45K High: $174.54K avg. 101.12% | Avg: $160.00K Low: $145.45K High: $174.54K avg. 0% | Avg: $18.10M Low: $16.45M High: $19.75M avg. 11215.29% | Avg: $28.68M Low: $26.08M High: $31.29M avg. 58.46% |
EPS
% change YoY
| -$34.33 N/A | -$2,714.18 -7806.14% | -$3.95 99.85% | Avg: -$1.44 Low: -$2.77 High: -$0.5 avg. 63.54% | Avg: -$1.46 Low: -$2.63 High: -$0.51 avg. -1.62% | Avg: -$0.75 Low: -$0.84 High: -$0.66 avg. 48.51% | Avg: -$0.26 Low: -$0.29 High: -$0.23 avg. 65.04% |
Operating Expenses
% change YoY
| $37.44M N/A | $37.37M -0.19% | $16.04M -57.05% | Avg: $983.36K Low: $893.97K High: $1.07M avg. -93.87% | Avg: $983.36K Low: $893.97K High: $1.07M avg. 0% | Avg: $111.27M Low: $101.15M High: $121.38M avg. 11215.30% | Avg: $176.32M Low: $160.29M High: $192.35M avg. 58.46% |
FAQ
What is Aprea Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 19.78% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -10.02M, average is -20.99M and high is -1.80M.
What is Aprea Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2804.87% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $242.42K, average is $266.67K and high is $290.91K.
What is Aprea Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 43.87% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$2.77, average is -$1.44 and high is $-0.5.
What is the best performing analyst?
In the last twelve months analysts have been covering Aprea Therapeutics stock. The most successful analyst is Robert Driscoll whose win rate is 100%. He has correctly predicted 1/1 price targets.